Skip to main content

19 publications

Name Date Type Actions

Buyback programs - november 2022

Monthly communication regarding buyback programs

08/12/2022 Description of buyback programs

Buyback programs - october 2022

Monthly communication regarding buyback programs

10/11/2022 Description of buyback programs

First nine months 2022 sales: €405M

In line with year-end outlook

12/10/2022 Public releases

Buyback programs - september 2022

Monthly communication regarding buyback programs

05/10/2022 Description of buyback programs

2022 HALF YEAR RESULTS Additional information on the Group’s strategy

Following the conference call organised on 15 September 2022 to present its half-year results, Vetoquinol would like to provide some additional information on the strategy implemented and its outlook.

23/09/2022 Public releases , Half Year Report

2022 HALF YEAR RESULTS

Sales: €271m (up 6.0% as reported)
Essentials sales: €154m (up 9.8% as reported)
EBIT before depreciation of acquired assets: €52m (19.0% of sales)
Net income - Group share: €21m (7.9% of sales)
EBITDA: €62m (22.9% of sales)

15/09/2022 Public releases

H1 2022 Sales

H1 2022 Sales: €271m, up 6.1%
+2.0% on a like-for-like basis
H1 2022 Essentials Sales: €154m, up 9.8%
+6.8% on a like-for-like basis

20/07/2022 Public releases

Remuneration vote results - AG may 2022

20/05/2022 Shareholders´s Meeting

Vote results - AG may 19, 2022

20/05/2022 Shareholders´s Meeting

Information regarding the total number of voting rights and shares making of the share capital - 12 may 2022

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers»

13/05/2022 Shareholders´s Meeting